Establishment Labs Holdings Common Stock Net 2017-2024 | ESTA
Establishment Labs Holdings common stock net from 2017 to 2024. Common stock net can be defined as the value of common equity ownership.
| Establishment Labs Holdings Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2023 | $316 |
| 2022 | $224 |
| 2021 | $220 |
| 2020 | $213 |
| 2019 | $148 |
| 2018 | $146 |
| 2017 | $41 |
| 2016 | $7 |
| Establishment Labs Holdings Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2024-06-30 | $368 |
| 2024-03-31 | $367 |
| 2023-12-31 | $316 |
| 2023-09-30 | $311 |
| 2023-06-30 | $310 |
| 2023-03-31 | $225 |
| 2022-12-31 | $224 |
| 2022-09-30 | $223 |
| 2022-06-30 | $222 |
| 2022-03-31 | $221 |
| 2021-12-31 | $220 |
| 2021-09-30 | $219 |
| 2021-06-30 | $216 |
| 2021-03-31 | $215 |
| 2020-12-31 | $213 |
| 2020-09-30 | $213 |
| 2020-06-30 | $212 |
| 2020-03-31 | $212 |
| 2019-12-31 | $148 |
| 2019-09-30 | $147 |
| 2019-06-30 | $146 |
| 2019-03-31 | $146 |
| 2018-12-31 | $146 |
| 2018-09-30 | $145 |
| 2018-06-30 | $58 |
| 2018-03-31 | $43 |
| 2017-12-31 | $41 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $7 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.292B | $0.165B |
| Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $98.015B | 12.16 |
| Cencora (COR) | United States | $48.948B | 18.05 |
| DiDi Global (DIDIY) | China | $23.622B | 0.00 |
| ICON (ICLR) | Ireland | $17.731B | 15.79 |
| Natera (NTRA) | United States | $16.587B | 0.00 |
| Viatris (VTRS) | United States | $15.469B | 4.76 |
| Avantor (AVTR) | United States | $15.375B | 23.05 |
| Revvity (RVTY) | United States | $14.905B | 25.89 |
| BioMerieux (BMXMF) | France | $13.087B | 0.00 |
| CochLear (CHEOY) | Australia | $12.590B | 0.00 |
| Solventum (SOLV) | United States | $12.509B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.276B | 31.77 |
| Charles River Laboratories (CRL) | United States | $11.014B | 21.28 |
| Doximity (DOCS) | United States | $10.815B | 64.01 |
| HealthEquity (HQY) | United States | $8.629B | 46.83 |
| Sonic Healthcare (SKHHY) | Australia | $8.542B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $7.043B | 32.79 |
| Life Times (LTH) | United States | $5.170B | 34.22 |
| Sotera Health (SHC) | United States | $4.557B | 24.38 |
| Organon (OGN) | United States | $4.131B | 4.17 |
| Surgery Partners (SGRY) | United States | $3.859B | 42.76 |
| BrightSpring Health Services (BTSG) | United States | $3.408B | 72.48 |
| PACS (PACS) | United States | $3.251B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.620B | 0.00 |
| Concentras Parent (CON) | United States | $2.500B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.337B | 0.00 |
| Premier (PINC) | United States | $2.292B | 11.44 |
| GeneDx Holdings (WGS) | United States | $2.137B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.856B | 48.90 |
| Teladoc Health (TDOC) | United States | $1.589B | 0.00 |
| Progyny (PGNY) | United States | $1.499B | 26.37 |
| Pediatrix Medical (MD) | United States | $1.353B | 13.24 |
| CareDx (CDNA) | United States | $1.268B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.104B | 7.49 |
| Embecta (EMBC) | United States | $0.897B | 5.98 |
| InnovAge Holding (INNV) | United States | $0.813B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.757B | 0.00 |
| SBC Medicals (SBC) | United States | $0.706B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.469B | 0.00 |
| DocGo (DCGO) | United States | $0.409B | 15.38 |
| Enhabit (EHAB) | United States | $0.397B | 34.30 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.373B | 0.00 |
| LifeMD (LFMD) | United States | $0.252B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.225B | 0.00 |
| ModivCare (MODV) | United States | $0.221B | 12.05 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| Biodesix (BDSX) | United States | $0.199B | 0.00 |
| Nutex Health (NUTX) | United States | $0.160B | 0.00 |
| MultiPlan (MPLN) | United States | $0.137B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.129B | 0.00 |
| So-Young (SY) | China | $0.089B | 21.63 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.055B | 0.00 |
| OncoCyte (OCX) | United States | $0.048B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.11 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Oncology Institute (TOI) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |